Whooping cough, or pertussis, is a highly contagious respiratory infection caused by bacteria called Bordetella pertussis. The infection attacks the lining of the breathing passages. People can get ...

Condition affects about 16m people per year, and accounts for about 160,700 deaths in children younger than five ...

Whooping cough cases have surged to their highest levels since 2014, with health experts urging vaccinations and preventative ...

Mohan said whooping cough is a contagious respiratory disease caused by Bordetella pertussis, a bacteria that only affects humans. Cold-like symptoms are usually the first signs of whooping cough.

Aaron M. Wendelboe, PhD; Elisabeth Njamkepo, PhD; Antoine Bourillon, MD; D Daniel Floret, MD; Joel Gaudelus, MD; Michael Gerber, MD; Emmanuel Grimprel, MD, PhD; David ...

Whooping cough, caused by a bacteria called Bordetella pertussis, starts sneakily enough. You might think you just have a cold at first with the usual suspects: runny nose, mild fever and some ...

The number of whooping cough cases in Florida soared in 2024. From Jan. 1, 2024 to Dec. 31, 2024, the Florida Department of Health reported 715 cases of pertussis – an eight-fold increase over ...

Whooping cough, due to Bordetella pertussis and Bordetella parapertussis, is an important cause of childhood morbidity and mortality. Despite widespread pertussis immunization in childhood ...

The best defense against pertussis is vaccination. The DTaP vaccine and the Tdap booster provide effective protection, reducing the risk of severe illness and limiting the spread. Parents should ...

It’s caused by the highly contagious bacterium Bordetella pertussis and can be fatal for children under 1 year old. Pertussis is easily prevented by vaccination, but immunization wears off over ...

ILiAD is a late-stage biotech development company, which has raised over $100m to date, and is dedicated to the prevention of whooping cough, a life-threatening disease caused by Bordetella pertussis.

The AIM-traded firm said it would be the world's first phase three human challenge study for Bordetella pertussis, marking a significant milestone in vaccine development. It said the trial was ...